1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > Diagnostics Focus 08 DECEMBER 2014

Diagnostics Focus 08 DECEMBER 2014

  • December 2014
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Ariosa Acquisition To Benefit Roche's Cancer Diagnostics
Industry Brief - IDT/Ubiquitome To Co-Develop Mobile Ebola Test
Industry Brief - QIAGEN To Distribute altona's RealStar Ebolavirus RT-PCR Kit 1.0 Globally
Industry Brief - Exiqon In-Licenses Validated PCA Biomarkers From Aarhus University Hospital
Industry Brief - Nanomix Secures ISO Certification
Industry Brief - Ignyta US Diagnostic Laboratory Awarded CLIA Certification
Industry Brief - Leica Completes Devicor Takeover
Industry Brief - Illumina/Sequenom Pool NIPT Intellectual Property And Settle Outstanding Patent Disputes
Industry Brief - Eurofins To Acquire Boston Heart Diagnostics
Industry Brief - Diagnostics 510(k) Clearances - November 2014
Industry Brief - CMS To Reimburse Cologuard Test At USD502
Industry Brief - Spartan RXCYP2C19 Rapid DNA Test System Approved In Korea
Industry Brief - Hologic's Aptima HIV-1 Viral Load Test Granted EU Clearance
Industry Brief - Sentosa NGS System FDA Listed As Class II Device
Industry Brief - Health Canada Issues Alert Against Unauthorised OraQuick HIV Test Kits Sales
Industry Brief - Xpert Norovirus Test Granted US Marketing Clearance
Industry Brief - Saladax Launches MyImatinib Chemotherapy Exposure Optimisation Test In US
Industry Brief - Roche Launches cobas HIV-1/HCV Assays In Markets Accepting CE Mark
Industry Brief - Siemens' Rapid Gram-Negative Combo Panels Recall Marked As Class I
Industry Brief - CFDA Approves Epi proColon Test For CRC Screening
Industry Brief - FDA Grants CLIA Waiver For Alere Determine HIV-1/2 Ag/Ab Combo
Industry Brief - Cancer Genetics Launches Targeted NGS Panel For CLL
Industry Brief - Latest Clinical Oncology Diagnostic Highlights Presented At EORTC-NCI-AACR
Industry Trend Analysis - Singapore Diagnostic Development Hub Expedites Country's Cancer Detection Drive
Industry Brief - immunoSEQ Assay Predicts Response To Keytruda
Industry Brief - Venaxis Submits Response To FDA's AI Request Regarding APPY1 Test

Table Of Contents

Diagnostics Focus 08 DECEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review,  Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.